Evidence map›Paper›PMID 17289570›Full record

ArticleCell2007

Histone methylation-dependent mechanisms impose ligand dependency for gene activation by nuclear receptors.

Ivan Garcia-Bassets, Young-Soo Kwon, Francesca Telese, Gratien G Prefontaine, Kasey R Hutt, Christine S Cheng, Bong-Gun Ju, Kenneth A Ohgi, Jianxun Wang, Laure Escoubet-Lozach and 4 more

Abstract read
In one paragraph

Article in Cell, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 257 papers.

0numbers the graph read from it
0cells of the map it votes in
257citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

257 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Strategies that regulate LSD1 for novel therapeutics.Acta pharmaceutica Sinica. B · 2024
    Review
  15. Review
  16. Article
  17. Review
  18. Inducible CRISPR Epigenome Systems Mimic Cocaine Induced Bidirectional Regulation of Nab2 and Egr3.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2023
    Article
  19. Review
  20. Review

197 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Ivan Garcia-Bassets *Howard Hughes Medical Institute, Department of Molecular Medicine, University of California, San Diego, School of Medicine 9500 Gilman Drive, La Jolla, CA 92093-0648.
Young-Soo Kwon *Department of Cellular and Molecular Medicine, University of California, San Diego, School of Medicine 9500 Gilman Drive, La Jolla, CA 92093-0648.
Francesca TeleseHoward Hughes Medical Institute, Department of Molecular Medicine, University of California, San Diego, School of Medicine 9500 Gilman Drive, La Jolla, CA 92093-0648.
Gratien G PrefontaineHoward Hughes Medical Institute, Department of Molecular Medicine, University of California, San Diego, School of Medicine 9500 Gilman Drive, La Jolla, CA 92093-0648.
Kasey R HuttHoward Hughes Medical Institute, Department of Molecular Medicine, University of California, San Diego, School of Medicine 9500 Gilman Drive, La Jolla, CA 92093-0648.
Christine S ChengHoward Hughes Medical Institute, Department of Molecular Medicine, University of California, San Diego, School of Medicine 9500 Gilman Drive, La Jolla, CA 92093-0648.
Bong-Gun JuHoward Hughes Medical Institute, Department of Molecular Medicine, University of California, San Diego, School of Medicine 9500 Gilman Drive, La Jolla, CA 92093-0648.
Kenneth A OhgiHoward Hughes Medical Institute, Department of Molecular Medicine, University of California, San Diego, School of Medicine 9500 Gilman Drive, La Jolla, CA 92093-0648.
Jianxun WangHoward Hughes Medical Institute, Department of Molecular Medicine, University of California, San Diego, School of Medicine 9500 Gilman Drive, La Jolla, CA 92093-0648.
Laure Escoubet-LozachDepartment of Cellular and Molecular Medicine, University of California, San Diego, School of Medicine 9500 Gilman Drive, La Jolla, CA 92093-0648.
David W RoseDepartment of Medicine, Division of Endocrinology and Metabolism, University of California, San Diego, School of Medicine 9500 Gilman Drive, La Jolla, CA 92093-0648.
Christopher K GlassDepartment of Cellular and Molecular Medicine, University of California, San Diego, School of Medicine 9500 Gilman Drive, La Jolla, CA 92093-0648.
Xiang-Dong FuDepartment of Cellular and Molecular Medicine, University of California, San Diego, School of Medicine 9500 Gilman Drive, La Jolla, CA 92093-0648.
Michael G RosenfeldHoward Hughes Medical Institute, Department of Molecular Medicine, University of California, San Diego, School of Medicine 9500 Gilman Drive, La Jolla, CA 92093-0648.

Funding

Transgenic & Knock-out MouseP30DK063491 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ALAN R. SALTIEL · 2003 to 2026
$40.4M
REGULATION OF NEUROENDOCRINE SWITCHING EVENTSR37DK039949 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ROSENFELD, MICHAEL G · 1987 to 2020
$12.3M
Ligand Regulated Epigenetic/Nuclear Architectural Strategies and Human DiseaseR01NS034934 · NINDS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ROSENFELD, MICHAEL G · 1995 to 2013
$6.8M
TRANSCRIPTIONAL COREGULATORS AND MYELOID GENE EXPRESSIONR01CA052599 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI GLASS, CHRISTOPHER K · 1991 to 2010
$4.6M
Repressors in Prostate CancerR01CA097134 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ROSENFELD, MICHAEL G · 2002 to 2012
$3.2M
REGULATION OF NEUROENDOCRINE SWITCHING EVENTSR01DK039949 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ROSENFELD, MICHAEL G · 1996 to 2024
$2.4M
Typing the Transcriptome in Cancer Using Splicing ArrayR33CA114184 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI FU, XIANG-DONG · 2005 to 2007
$1.6M
A novel ChIP-on-Chip technology for ENCODER01HG003119 · NHGRI · UNIVERSITY OF CALIFORNIA SAN DIEGO · PI FU, XIANG-DONG · 2003 to 2005
$1.4M
NCI NIH HHS CA114184NCI NIH HHS CA52599NCI NIH HHS CA97134NCI NIH HHS R01 CA052599NCI NIH HHS R01 CA097134NCI NIH HHS R33 CA114184NHGRI NIH HHS HG003119NHGRI NIH HHS R01 HG003119NIDDK NIH HHS DK063491NIDDK NIH HHS DK39949NIDDK NIH HHS P30 DK063491NIDDK NIH HHS R01 DK039949NIDDK NIH HHS R37 DK039949NINDS NIH HHS NS34934NINDS NIH HHS R01 NS034934
6 · The paper itself

Abstract

Nuclear receptors undergo ligand-dependent conformational changes that are required for corepressor-coactivator exchange, but whether there is an actual requirement for specific epigenetic landmarks to impose ligand dependency for gene activation remains unknown. Here we report an unexpected and general strategy that is based on the requirement for specific cohorts of inhibitory histone methyltransferases (HMTs) to impose gene-specific gatekeeper functions that prevent unliganded nuclear receptors and other classes of regulated transcription factors from binding to their target gene promoters and causing constitutive gene activation in the absence of stimulating signals. This strategy, based at least in part on an HMT-dependent inhibitory histone code, imposes a requirement for specific histone demethylases, including LSD1, to permit ligand- and signal-dependent activation of regulated gene expression. These events link an inhibitory methylation component of the histone code to a broadly used strategy that circumvents pathological constitutive gene induction by physiologically regulated transcription factors.

Indexed as

Gene Expression RegulationCell Line, TumorChromatin ImmunoprecipitationEstradiolEstrogen Receptor alphaGenome, HumanHistone CodeHistone DemethylasesHistone-Lysine N-MethyltransferaseHistonesHumansLigandsMethylationOxidoreductases, N-DemethylatingPromoter Regions, GeneticTranscriptional ActivationEstradiolEstrogen Receptor alphaHistone DemethylasesHistone-Lysine N-MethyltransferaseHistonesKDM1A protein, humanLigandsOxidoreductases, N-Demethylating

Identifiers

PMID17289570
PMCPMC1994663

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.